Company Tyme Technologies Inc Other OTC
Equities
US90238J1034
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 54 | 23/11/20 | |
Lisa M. Wilson
IRC | Investor Relations Contact | 59 | - |
Barbara Galaini
AUD | Comptroller/Controller/Auditor | 66 | - |
John M. Rothman
PRN | Corporate Officer/Principal | 75 | 18/08/20 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 54 | 23/11/20 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 172,206,894 | 139,643,067 ( 81.09 %) | 0 | 81.09 % |
Company contact information
Tyme Technologies, Inc.
35 CambridgePark Drive 4th floor
02140, Cambridge
+212 461 2315
https://www.tymeinc.com/![address Tyme Technologies Inc](https://cdn.zonebourse.com/static/address/18088200.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+20.98% | 127B | |
+23.52% | 117B | |
+26.32% | 27.67B | |
-20.11% | 20.33B | |
-16.13% | 16.79B | |
-17.59% | 15.63B | |
+13.15% | 14.84B | |
-47.70% | 14.65B | |
+58.73% | 14.43B |